Must See: Next 10 Yrs Belong to this Sector
Here is the latest financial fact sheet of AJANTA PHARMA. For more details, see the AJANTA PHARMA quarterly results and AJANTA PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 1.0 |
No. of shares | m | 128.13 |
1 Week | % | 2.7 |
1 Month | % | 1.5 |
1 Year | % | -4.6 |
52 week H/L | Rs | 1,425.8/1,062.2 |
No. of Mths Year Ending |
12 Mar-18* |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
5-Yr Chart Click to enlarge
|
---|
AJANTA PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 1,818 | 1,422 | 1,544 | 1,883 | 1,614 | |
Low | Rs | 1,106 | 898 | 840 | 1,258 | 1,089 | |
Sales per share (Unadj.) | Rs | 241.0 | 235.6 | 296.6 | 334.0 | 391.1 | |
Earnings per share (Unadj.) | Rs | 53.2 | 44.4 | 53.6 | 75.6 | 83.4 | |
Diluted earnings per share | Rs | 36.6 | 30.2 | 36.5 | 51.0 | 55.6 | |
Cash flow per share (Unadj.) | Rs | 60.0 | 52.6 | 64.6 | 89.0 | 98.1 | |
Dividends per share (Unadj.) | Rs | 0 | 9.00 | 13.00 | 9.50 | 9.50 | |
Adj. dividends per share | Rs | 0.00 | 6.13 | 8.85 | 6.42 | 6.33 | |
Avg Dividend yield | % | 0 | 0.8 | 1.1 | 0.6 | 0.7 | |
Book value per share (Unadj.) | Rs | 231.8 | 257.2 | 297.8 | 346.1 | 382.1 | |
Adj. book value per share | Rs | 159.2 | 175.1 | 202.8 | 233.8 | 254.8 | |
Shares outstanding (eoy) | m | 88.01 | 87.25 | 87.25 | 86.53 | 85.42 | |
Price / Sales ratio | x | 6.1 | 4.9 | 4.0 | 4.7 | 3.5 | |
Avg P/E ratio | x | 27.5 | 26.1 | 22.2 | 20.8 | 16.2 | |
P/CF ratio (eoy) | x | 24.4 | 22.0 | 18.5 | 17.7 | 13.8 | |
Price / Book Value ratio | x | 6.3 | 4.5 | 4.0 | 4.5 | 3.5 | |
Dividend payout | % | 0 | 20.3 | 24.3 | 12.6 | 11.4 | |
Avg Mkt Cap | Rs m | 128,677 | 101,190 | 103,993 | 135,898 | 115,433 | |
Total wages/salary | Rs m | 3,765 | 4,307 | 4,856 | 5,483 | 6,458 |
AJANTA PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 21,207 | 20,554 | 25,879 | 28,897 | 33,410 | |
Other income | Rs m | 242 | 211 | 922 | 260 | 1,157 | |
Total revenues | Rs m | 21,448 | 20,765 | 26,801 | 29,157 | 34,567 | |
Gross profit | Rs m | 6,584 | 5,664 | 6,794 | 9,986 | 9,293 | |
Depreciation | Rs m | 596 | 721 | 957 | 1,161 | 1,253 | |
Interest | Rs m | 4 | 12 | 119 | 83 | 102 | |
Profit before tax | Rs m | 6,226 | 5,143 | 6,640 | 9,002 | 9,095 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 1,539 | 1,273 | 1,963 | 2,463 | 1,968 | |
Profit after tax | Rs m | 4,686 | 3,870 | 4,677 | 6,539 | 7,127 | |
Gross profit margin | % | 31.0 | 27.6 | 26.3 | 34.6 | 27.8 | |
Effective tax rate | % | 24.7 | 24.8 | 29.6 | 27.4 | 21.6 | |
Net profit margin | % | 22.1 | 18.8 | 18.1 | 22.6 | 21.3 |
AJANTA PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 12,236 | 13,005 | 17,811 | 22,178 | 24,548 | |
Current liabilities | Rs m | 3,461 | 4,984 | 7,455 | 8,388 | 8,377 | |
Net working cap to sales | % | 41.4 | 39.0 | 40.0 | 47.7 | 48.4 | |
Current ratio | x | 3.5 | 2.6 | 2.4 | 2.6 | 2.9 | |
Inventory Days | Days | 47 | 43 | 36 | 53 | 42 | |
Debtors Days | Days | 8 | 8 | 11 | 9 | 11 | |
Net fixed assets | Rs m | 12,024 | 16,053 | 17,909 | 18,912 | 19,259 | |
Share capital | Rs m | 177 | 175 | 175 | 174 | 172 | |
"Free" reserves | Rs m | 20,221 | 22,266 | 25,809 | 29,777 | 32,469 | |
Net worth | Rs m | 20,397 | 22,441 | 25,984 | 29,951 | 32,640 | |
Long term debt | Rs m | 10 | 7 | 7 | 16 | 16 | |
Total assets | Rs m | 24,260 | 29,058 | 35,720 | 41,090 | 43,807 | |
Interest coverage | x | 1,519.4 | 444.3 | 56.7 | 109.8 | 90.2 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.9 | 0.7 | 0.7 | 0.7 | 0.8 | |
Return on assets | % | 19.3 | 13.4 | 13.4 | 16.1 | 16.5 | |
Return on equity | % | 23.0 | 17.2 | 18.0 | 21.8 | 21.8 | |
Return on capital | % | 30.5 | 23.0 | 26.0 | 30.3 | 28.2 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 11,667 | 10,682 | 14,421 | 18,097 | 18,678 | |
Fx outflow | Rs m | 1,616 | 2,102 | 1,642 | 2,315 | 3,662 | |
Net fx | Rs m | 10,052 | 8,580 | 12,778 | 15,782 | 15,016 |
AJANTA PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 2,811 | 3,745 | 4,568 | 5,763 | 5,620 | |
From Investments | Rs m | -2,561 | -2,228 | -2,244 | -2,824 | -741 | |
From Financial Activity | Rs m | -2 | -1,475 | -1,286 | -3,183 | -4,600 | |
Net Cashflow | Rs m | 248 | 43 | 1,037 | -244 | 279 |
Share Holding
Shareholding as on Dec 2022
|
Company Information
|
CHM: Mannalal B Agrawal | COMP SEC: Gaurang Shah | YEAR OF INC: 1979 | BSE CODE: 532331 | FV (Rs): 2 | DIV YIELD (%): 0.5 |
Read: AJANTA PHARMA 2021-22 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: AUROBINDO PHARMA CIPLA PIRAMAL ENTERPRISES SUN PHARMA LUPIN
Compare AJANTA PHARMA With: AUROBINDO PHARMA CIPLA PIRAMAL ENTERPRISES SUN PHARMA LUPIN
After making a flat start, Indian share markets swung between gains and losses as the session progressed but fell sharply during closing hours.